Incidence of Rotavirus and Circulating Genotypes in Northeast Brazil during 7 Years of National Rotavirus Vaccination
暂无分享,去创建一个
L. Cuevas | M. Iturriza-Gómara | V. S. Santos | N. Cunliffe | R. Gurgel | S. Dolabella | Alberto De Juan Alvarez | Alda Rodrigues | Robergson R. Ribeiro | Natanael L. Da Mota
[1] J. Matthijnssens,et al. Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] J. Muyembe,et al. Molecular Surveillance of Rotavirus Infection in the Democratic Republic of the Congo August 2009 to June 2012 , 2014, The Pediatric infectious disease journal.
[3] J. Tate,et al. Effectiveness and impact of rotavirus vaccines in the United States – 2006–2012 , 2014, Expert review of vaccines.
[4] G. Armah,et al. Surveillance for Rotavirus Gastroenteritis in Children Less Than 5 Years of Age in Togo , 2014, The Pediatric infectious disease journal.
[5] K. Mitiku,et al. Hospital-based Surveillance for Rotavirus Gastroenteritis in Children Younger Than 5 Years of Age in Ethiopia: 2007–2012 , 2014, The Pediatric infectious disease journal.
[6] T. Vesikari,et al. Impact and Effectiveness of RotaTeq® Vaccine Based on 3 Years of Surveillance Following Introduction of a Rotavirus Immunization Program in Finland , 2013, The Pediatric infectious disease journal.
[7] Martin J. Aryee,et al. Global Causes of Diarrheal Disease Mortality in Children <5 Years of Age: A Systematic Review , 2013, PloS one.
[8] A. Ciapponi,et al. Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries. , 2013, Vaccine.
[9] J. Tate,et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] E. Anderson,et al. Rotavirus vaccination: short-term indirect herd protection, long-term uncertainty , 2013, Expert review of vaccines.
[11] C. M. Mendes,et al. Temporal trends of overall mortality and hospital morbidity due to diarrheal disease in Brazilian children younger than 5 years from 2000 to 2010. , 2013, Jornal de pediatria.
[12] J. Matthijnssens,et al. Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes? , 2012, Expert review of vaccines.
[13] A. Dey,et al. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program , 2012, The Medical journal of Australia.
[14] B. Cheuvart,et al. Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins. , 2011, Vaccine.
[15] A. Nurchi,et al. Epidemiology and prevention of rotavirus infection: an underestimated issue? , 2011, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[16] M. Kundi,et al. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. , 2011, Vaccine.
[17] A. Ciapponi,et al. Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta‐analysis , 2011, Reviews in medical virology.
[18] J. Matthijnssens,et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. , 2010, Vaccine.
[19] S. Todd,et al. Rotavirus strain types circulating in Africa: Review of studies published during 1997-2006. , 2010, The Journal of infectious diseases.
[20] Manish M Patel,et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. , 2010, The Journal of infectious diseases.
[21] T. R. Oliveira,et al. Tendencias de la internación y de la mortalidad infantil por diarrea: Brasil, 1995 a 2005 , 2010 .
[22] Toyoko Nakagomi,et al. Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. , 2009, Gastroenterology.
[23] L. Cuevas,et al. Effect of rotavirus vaccination on circulating virus strains , 2008, The Lancet.
[24] L. Cuevas,et al. Predominance of Rotavirus P[4]G2 in a Vaccinated Population, Brazil , 2007, Emerging infectious diseases.
[25] Penelope H Dennehy. Rotavirus vaccines--an update. , 2007, Vaccine.
[26] T. Vesikari,et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.
[27] J. Heyse,et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.
[28] Toyoko Nakagomi,et al. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. , 2005, The Journal of infectious diseases.
[29] G. Browning,et al. Rotavirus serotype G3 predominates in horses , 1992, Journal of clinical microbiology.
[30] Rotavirus vaccines WHO position paper: January 2013 - Recommendations. , 2013, Vaccine.
[31] M. Latorre,et al. Trends in hospital admission and infant mortality from diarrhea: Brazil, 1995-2005. , 2010, Revista de saude publica.